Testing gene therapy vectors in human primary nasal epithelial cultures

about

Barriers to inhaled gene therapy of obstructive lung diseases: A review Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia.Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.

P2860

Q29248141-FA4FCC2E-1F0E-4FED-913C-35F48D25DBE0 Q33825789-80EB31AF-1F4F-437B-B0D8-2A23DD3F07E1 Q40341616-27F55864-FDB9-42CA-96AB-70D4DE66F42B

P2860

Testing gene therapy vectors in human primary nasal epithelial cultures

Item

http://www.wikidata.org/entity/Q41889552

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Testing gene therapy vectors in human primary nasal epithelial cultures

@en

type

Item

label

Testing gene therapy vectors in human primary nasal epithelial cultures

@en

prefLabel

Testing gene therapy vectors in human primary nasal epithelial cultures

@en

P1476

Testing gene therapy vectors in human primary nasal epithelial cultures

@en

P2093

Cathleen Duan

http://www.w3.org/2001/XMLSchema#string

Christine E Bear

http://www.w3.org/2001/XMLSchema#string

Herman Yeger

http://www.w3.org/2001/XMLSchema#string

Hong Ouyang

http://www.w3.org/2001/XMLSchema#string

Huibi Cao

http://www.w3.org/2001/XMLSchema#string

Jim Hu

http://www.w3.org/2001/XMLSchema#string

Jing Wu

http://www.w3.org/2001/XMLSchema#string

Julie Avolio

http://www.w3.org/2001/XMLSchema#string

Kai Du

http://www.w3.org/2001/XMLSchema#string

Tanja Gonska

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy: light is finally in the tunnel

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia.

Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.

Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis.

Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors

P304

15034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTM.2015.34

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26730394

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4685663

http://www.w3.org/2001/XMLSchema#string

Testing gene therapy vectors in human primary nasal epithelial cultures

about

P2860

P2860

Testing gene therapy vectors in human primary nasal epithelial cultures

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932